Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. (Q38194642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

review article

1 reference

title

Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

chronic inflammatory demyelinating polyradiculoneuropathy

10 March 2020

main subject

0 references

author

Eduardo Nobile-Orazio

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Eduardo Nobile-Orazio

series ordinal

1

1 reference

30 August 2017

publication date

1 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Peripheral Nervous System

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

2-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

Focal CIDP presenting as chronic progressive monomelic sensory neuropathy.

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Intravenous immunoglobulin inhibits BAFF production in chronic inflammatory demyelinating polyneuropathy - a new mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic inflammatory demyelinating polyneuropathy and respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Distal acquired demyelinating symmetric neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Anti-neurofascin antibody in patients with combined central and peripheral demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Motor-dominant chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Recurrences, vaccinations and long-term symptoms in GBS and CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Clinical features of CIDP with LM1-associated antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Incidence and prevalence of CIDP and the association of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Recovery of the T-cell repertoire in CIDP by IV immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Neurofascin as a target for autoantibodies in peripheral neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Multifocal motor neuropathy: current concepts and controversies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

"Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

A case of chronic sensory demyelinating neuropathy responding to immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Relapsing neuropathy due to tetanus toxoid. Report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Lewis-sumner syndrome of pure upper-limb onset: diagnostic, prognostic, and therapeutic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic inflammatory pure sensory polyradiculoneuropathy: a rare CIDP variant with unusual electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

The spectrum of chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Clinical spectrum of chronic acquired demyelinating polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

The safety profile of home infusion of intravenous immunoglobulin in patients with neuroimmunologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12053

21 January 2018

Identifiers

DOI

10.1111/JNS5.12053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24612201%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference